Skip to main content
Fig. 1 | Microbiome

Fig. 1

From: Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder

Fig. 1

Overview of the study design. The workflow schematic diagram for this study illustrates the details of sample groups and multi-omic data collection. MDD patients were treated with ESC for 12 weeks, and treatment outcomes were evaluated at week 2 (early) and week 12 (endpoint). All patients were divided into remitter (R, HAMD-17 ≤ 7) and non-remitter (NR, HAMD-17 > 7) groups according to the HAMD-17 score at week 12

Back to article page

Microbiome

ISSN: 2049-2618

Contact us